| 1 |
Medicare physician payment and MEI-linked reform |
AMGA, AMA, AAFP, TMA, ACP, MGMA, ACS |
Broad agreement that annual statutory updates and temporary patches are inadequate; durable inflation-linked reform is favored. |
Budget planning and recruitment risk across every specialty. |
| 2 |
Modifier 25 same-day E/M and global procedure reduction |
AMA, AAFP, AAP, ACOG, ACP, ACS, MGMA, TMA; AMGA |
Formal coalition opposition to the 50% reduction; AMGA also identified it as a top member concern. |
Highest immediate risk for office-based procedural specialties. |
| 3 |
Practice expense methodology and specialty redistribution |
AMGA, AMA, MGMA, ACS |
Concern about broad redistribution and implementation without adequate specialty-specific validation. |
Requires CPT, site-of-service, and specialty modeling. |
| 4 |
RPM and RTM staffing, initiating visit, and valuation |
AMGA, AMA, MGMA, ACP |
Operational concern, especially direct-employment-only clinical staff and payment/coding changes. |
Could invalidate outsourced workflows and alter program economics. |
| 5 |
G2211 replacement with MOD1 and MOD2 |
AMGA, NAACOS, AAFP, ACP, AMA |
Generally viewed as a major longitudinal-care payment change; support is strongest for accountable/primary care, with implementation and redistribution concerns. |
Potential primary care revenue opportunity and ACO cost/assignment change. |
| 6 |
MIPS sunset, MVPs, core measures, PI, and ePA |
AMA, AMGA, TMA, MGMA, NAACOS |
Support for burden relief is mixed with concern about a mandatory MVP transition and readiness for new reporting requirements. |
Requires group-wide reporting strategy before 2029 and ePA readiness for 2028. |
| 7 |
QP status at the TIN/NPI and Advanced APM thresholds |
AMGA, AMA, NAACOS |
Concern that limiting benefits to participating TIN/NPI combinations fragments clinician obligations and weakens entity-level participation. |
Multi-TIN physicians may be QPs at the physician group but MIPS-subject elsewhere. |
| 8 |
MSSP benchmark methodology, ACPT, Level E, and ENHANCED |
NAACOS, AMGA, AMA, MGMA |
NAACOS supports Level E 60% and prior-savings/ACPT protections, but opposes or questions the ENHANCED regional reduction and the 5% cap. |
Affects ACO financial modeling and track-selection analysis. |
| 9 |
MSSP quality, APP Plus, Medicare eCQMs, and CEHRT |
NAACOS, AMGA, AMA, MGMA |
NAACOS calls the quality package a major win; stakeholders favor transition flexibility and lower reporting burden. |
Could reduce burden, but only if EHR and registry workflows are reliable and auditable. |
| 10 |
Ambulatory Specialty Model |
AMGA, ACS, AMA, MGMA |
AMGA continues to oppose mandatory, duplicative specialist accountability and seeks voluntary, aligned design. |
Recruiting, compensation, and all-Part-B payment exposure for selected specialists. |
| 11 |
Assignment and beneficiary eligibility |
NAACOS, AMGA, AMA |
Potential to reduce attribution leakage and expand assignment, with concern about higher-cost added beneficiaries and uneven ACO effects. |
Could improve retention but change population risk. |
| 12 |
Maternity coding transition |
ACOG, AMA, MGMA |
ACOG supports the new CPT structure and opposes parallel legacy Medicare G-codes; operational preparation is still required. |
OB/GYN coding, payer-contract, and workflow transition. |